Anti-PDCL3 antibody (STJA0009661)

SKU:
STJA0009661

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Phosducin-like protein 3 is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: PDCL3
Gene ID: 79031
Uniprot ID: PDCL3_HUMAN
Specificity: This antibody detects endogenous levels of PDCL3 at Human, Mouse, Rat
Immunogen: Synthesized peptide derived from human PDCL3
Post Translational Modifications N-terminal methionine acetylation destabilizes the protein.
Function Acts as a chaperone for the angiogenic VEGF receptor KDR/VEGFR2, increasing its abundance by inhibiting its ubiquitination and degradation. Inhibits the folding activity of the chaperonin-containing T-complex (CCT) which leads to inhibition of cytoskeletal actin folding. Acts as a chaperone during heat shock alongside HSP90 and HSP40/70 chaperone complexes. Modulates the activation of caspases during apoptosis.
Protein Name Phosducin-Like Protein 3
Htphlp
Phpl3
Viral Iap-Associated Factor 1
Viaf-1
Cellular Localisation Cytoplasm
Perinuclear Region
Endoplasmic Reticulum
Alternative Antibody Names Anti-Phosducin-Like Protein 3 antibody
Anti-Htphlp antibody
Anti-Phpl3 antibody
Anti-Viral Iap-Associated Factor 1 antibody
Anti-Viaf-1 antibody
Anti-PDCL3 antibody
Anti-PhLP2A antibody
Anti-VIAF1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance